SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

MEDP

Medpace Holdings Inc.
NASDAQHealth Care

Latest close: 618.47 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 30, 2026Reported sale · Form 4August J. Troendle, President & CEO · $13.7MOpen the filing ↗
  2. Sep 29, 2026Reported sale · Form 4August J. Troendle, President & CEO · $16.6MOpen the filing ↗
  3. Sep 28, 2026Reported sale · Form 4August J. Troendle, President & CEO · $1.5MOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record9037 flagged findings
Reported transactions (Form 4)80since Feb 13, 2026 · and 3 other holdings
Corporate events (8-K)30since May 4, 2018

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

Medpace Holdings, Inc. is a global clinical research organization (CRO) based in Cincinnati, Ohio, employing approximately 6,000 people. Operating under a full-service model, the company also offers global central laboratory, imaging core laboratory, and bioanalytical laboratory services, as well as a Phase I unit located on its headquarters and clinical research campus in Cincinnati, Ohio.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-07-23capital return (buybacks/dividends)freshOpen filing ↗
    “…As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the Company’s audited…”
    +1 more passage from the same document
    • “…with the Company’s audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K…”
  • 2026-04-23capital return (buybacks/dividends)recentOpen filing ↗
    “…As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the Company’s audited…”
    +1 more passage from the same document
    • “…with the Company’s audited consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 903)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

903 filings on record, the oldest from Apr 12, 16.

Listing the 25 most recent filings of the 903 on record.

8-Ks, explained

Structure19Governance17
  • Jun 4, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Apr 22, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Jul 21, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 16, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 21, 25StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Mar 31, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jul 3, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 29, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Mar 31, 23StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jan 18, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jan 3, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 16, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗

16 older filings not shown · The record reaches back to Oct 28, 16.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • August J. Troendle19.1%Sep 24, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 26, Kraft Robert O. filed notice of intent to sell up to $2.4M. That is about 0.01% of shares outstanding.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $2.4M on Aug 26, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+9 more recent notices · 7 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 30, 26Sell$13.7MAugust J. TroendlePresident & CEO↗
  • Sep 29, 26Sell$16.6MAugust J. TroendlePresident & CEO↗
  • Sep 28, 26Sell$1.5MAugust J. TroendlePresident & CEO↗
  • Sep 25, 26Sell$96KAugust J. TroendlePresident & CEO↗
  • Sep 24, 26Sell$17.3MAugust J. TroendlePresident & CEO↗
  • Sep 23, 26Sell$10.1MAugust J. TroendlePresident & CEO↗
  • Sep 22, 26Sell$30.8MAugust J. TroendlePresident & CEO↗
  • Sep 21, 26Sell$13.6MAugust J. TroendlePresident & CEO↗
  • Sep 17, 26Sell$6.7MAugust J. TroendlePresident & CEO↗
  • Sep 16, 26Sell$5.4MAugust J. TroendlePresident & CEO↗
  • Sep 15, 26Sell$9.9MAugust J. TroendlePresident & CEO↗
  • Aug 27, 26Sell$403KAugust J. TroendlePresident & CEO↗

There are 16 more transactions in this stretch.

Stock compensation, tax and giftsshow the 12 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 12, 26Compensation$500KSUSAN E BURWIGExec. VP, Operations↗
  • Oct 7, 26Compensation$333KSUSAN E BURWIGExec. VP, Operations↗
  • Sep 30, 26Compensationamount n/aRobert O. Kraft↗
  • Sep 30, 26Compensationamount n/aBrian T Carley↗
  • Sep 30, 26Compensationamount n/aCornelius P. McCarthy III↗
  • Sep 15, 26Compensation$500KSUSAN E BURWIGExec. VP, Operations↗
  • Aug 26, 26Compensation$325KRobert O. Kraft↗
  • Aug 20, 26Compensation$472KKevin M. BradyCFO & Treasurer↗
  • Aug 19, 26Compensation$255KFRED B DAVENPORT JR↗
  • Aug 19, 26Compensation$325KFRED B DAVENPORT JR↗
  • Aug 19, 26Compensation$300KFRED B DAVENPORT JR↗
  • Aug 7, 26Compensation$325KCornelius P. McCarthy III↗

The full record holds 240 transactions and goes back to Jan 16, 23.

Its sector and its market

Medpace Holdings Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Medpace Holdings Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Medpace Holdings Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
903 documents on file, from Apr 12, 2016 to Oct 14, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Medpace Holdings Inc. (MEDP): stock price history, insider trades and SEC filings — HornScout